Daito PharmaceuticalLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Daito PharmaceuticalLtd has a total shareholder equity of ¥52.1B and total debt of ¥12.1B, which brings its debt-to-equity ratio to 23.3%. Its total assets and total liabilities are ¥81.9B and ¥29.8B respectively. Daito PharmaceuticalLtd's EBIT is ¥3.7B making its interest coverage ratio -406.9. It has cash and short-term investments of ¥4.7B.
Anahtar bilgiler
23.3%
Borç/özkaynak oranı
JP¥12.14b
Borç
| Faiz karşılama oranı | -406.9x |
| Nakit | JP¥4.69b |
| Eşitlik | JP¥52.08b |
| Toplam yükümlülükler | JP¥29.85b |
| Toplam varlıklar | JP¥81.93b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 4577's short term assets (¥45.8B) exceed its short term liabilities (¥18.8B).
Uzun Vadeli Yükümlülükler: 4577's short term assets (¥45.8B) exceed its long term liabilities (¥11.1B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 4577's net debt to equity ratio (14.3%) is considered satisfactory.
Borcun Azaltılması: 4577's debt to equity ratio has increased from 14% to 23.3% over the past 5 years.
Borç Kapsamı: 4577's debt is well covered by operating cash flow (42.7%).
Faiz Kapsamı: 4577 earns more interest than it pays, so coverage of interest payments is not a concern.